| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/20/2002 | WO2002048377A2 Polynucleotide encoding chimeric protein and related vectors, cells, and methods of expression thereof |
| 06/20/2002 | WO2002048376A2 Bacterial host strains |
| 06/20/2002 | WO2002048370A2 Compositions and methods relating to colon specific genes and proteins |
| 06/20/2002 | WO2002048368A2 Proteins associated with cell growth, differentiation, and death |
| 06/20/2002 | WO2002048366A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/20/2002 | WO2002048365A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/20/2002 | WO2002048363A2 Human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
| 06/20/2002 | WO2002048359A1 Magnetic particle membrane-specific protein |
| 06/20/2002 | WO2002048358A2 Regulation of human chemokine-like receptor |
| 06/20/2002 | WO2002048348A1 Novel gene existing in human leukocyte antigen domain |
| 06/20/2002 | WO2002048347A1 Molecule correspondent to genotype and phenotype, composing elements thereof, method of producing the corespondent molecule and method of using the same |
| 06/20/2002 | WO2002048337A2 Secreted human proteins |
| 06/20/2002 | WO2002048194A1 Fusion protein having the enhanced in vivo activity of erythropoietin |
| 06/20/2002 | WO2002048189A2 Combinatorial libraries of proteins having the scaffold structure of c-type lectin-like domains |
| 06/20/2002 | WO2002048182A2 Interferon-alpha induced gene |
| 06/20/2002 | WO2002047730A2 Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins |
| 06/20/2002 | WO2002047721A1 Silensed anti-cd28 antibodies and use thereof |
| 06/20/2002 | WO2002047613A2 Immunogenic cancer peptides and uses thereof |
| 06/20/2002 | WO2002028905A3 Human anti-cd40 antibodies |
| 06/20/2002 | WO2002020730A3 Manganese lipoxygenase |
| 06/20/2002 | WO2002016436A3 ANTIBODIES TO HUMAN IL-1$g(b) |
| 06/20/2002 | WO2002012459A3 Method for improved production of cyanophycin and the secondary products thereof |
| 06/20/2002 | WO2002004600A3 Novel compounds |
| 06/20/2002 | WO2001090194A3 Antibodies against particular forms of propsa and use thereof in immunoassays |
| 06/20/2002 | WO2001090191A3 ANTIBODIES CAPABLE TO SELECTIVELY DETECT PRION PrPSc ISOFORMS |
| 06/20/2002 | WO2001085942A3 Cytoskeleton-associated proteins |
| 06/20/2002 | WO2001083524A3 Rna metabolism proteins |
| 06/20/2002 | WO2001074904A3 G-protein coupled receptors and nucleic acids encoding same |
| 06/20/2002 | WO2001072961A3 Novel compounds |
| 06/20/2002 | WO2001072830A3 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction |
| 06/20/2002 | WO2001068851A3 Polypeptides and nucleic acids encoding same |
| 06/20/2002 | WO2001060857A3 Compositions useful for regulating parkin gene activity |
| 06/20/2002 | WO2000077233A9 Complement-resistant non-mammalian dna viruses and uses thereof |
| 06/20/2002 | WO2000061750A9 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS |
| 06/20/2002 | WO2000061596A8 50 human secreted proteins |
| 06/20/2002 | WO2000050596A9 14273 receptor, a novel g-protein coupled receptor |
| 06/20/2002 | US20020077468 Corticotropin-releasing factor2 receptors |
| 06/20/2002 | US20020077466 Protein for use in the diagnosis, prevention and treatment of nervous system and cell proliferation, kidney and urogenital disorders |
| 06/20/2002 | US20020077465 Nuceotide sequences coding enzymatic polypeptide for use in the treatment and prevention of inflammation, cancer, muuscle disorders and thrombosis |
| 06/20/2002 | US20020077460 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
| 06/20/2002 | US20020077458 Nucleotide sequences for use in the diagnosis, treatment and prevention of apoptosis defects |
| 06/20/2002 | US20020077457 Nucleotide sequences coding binding protein for use as diagnostic tools in genetic engineering |
| 06/20/2002 | US20020077305 Genetic immunization with cationic lipids |
| 06/20/2002 | US20020077295 For therapy of cranial or cerebral trauma, spinal cord injury, stroke or a demyelinating disease |
| 06/20/2002 | US20020077288 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits |
| 06/20/2002 | US20020077270 Nucleic acids, proteins, and antibodies |
| 06/20/2002 | US20020076811 Mammalian artificial chromosomes |
| 06/20/2002 | US20020076793 Interleukin-1 beta converting enzyme like apoptosis protease-3 and 4 |
| 06/20/2002 | US20020076791 Cultured rodent cells; for use in generation of heterologous proteins |
| 06/20/2002 | US20020076763 Production of a multimeric protein by cell fusion method |
| 06/20/2002 | US20020076761 Polypeptides for use in human therapeutics and diagnostics |
| 06/20/2002 | US20020076755 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same |
| 06/20/2002 | US20020076750 Peptide for use as tools in human therapeutics and diagnostics |
| 06/20/2002 | US20020076745 Human g-protein chemokine receptor hdgnr10 (ccr5 receptor) |
| 06/20/2002 | US20020076705 Nucleotide sequences which code preferential polypeptide; for use in the detection, treatment, and prevention of alzheimer's, parkinson's, huntington's, Tourette Syndrome, meningitis, encephalitis, congenital disorders and brain |
| 06/20/2002 | US20020076453 Angiotensin I-converting enzyme inhibitory substance |
| 06/20/2002 | US20020076419 Ligands added to adenovirus fiber |
| 06/20/2002 | US20020076406 Multivalent target binding protein |
| 06/20/2002 | US20020076403 Recombinant protein containing a c-terminal fragment of plasmodium msp-1 |
| 06/20/2002 | US20020076394 Delivery system for gene therapy to the brain |
| 06/20/2002 | CA2436830A1 Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins |
| 06/20/2002 | CA2432736A1 Silenced anti-cd28 antibodies and use thereof |
| 06/20/2002 | CA2431646A1 Non-invasive method for detecting target rna |
| 06/20/2002 | CA2431362A1 P2y purinergic receptor expression for identifying preneoplastic and neoplastic states |
| 06/20/2002 | CA2430953A1 Combinatorial libraries of proteins having the scaffold structure of c-type lectin-like domains |
| 06/20/2002 | CA2430906A1 Proteins associated with cell growth, differentiation, and death |
| 06/20/2002 | CA2430905A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/20/2002 | CA2430901A1 Human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
| 06/20/2002 | CA2430736A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/20/2002 | CA2430297A1 Interferon-alpha induced gene |
| 06/20/2002 | CA2430249A1 Bacterial host strains |
| 06/20/2002 | CA2428216A1 Secreted proteins |
| 06/19/2002 | EP1215497A1 Diagnostics for transmissible spongiform encephalopathy |
| 06/19/2002 | EP1215283A1 NOVEL bHLH TYPE TRANSCRIPTION FACTOR GENE DEC2 |
| 06/19/2002 | EP1215282A1 Method of detecting trichothecene mycotoxins and reagent thereof |
| 06/19/2002 | EP1215281A1 Cyclic depsipeptide synthases, genes thereof and mass production system of cyclic depsipeptide |
| 06/19/2002 | EP1215214A1 Novel polypeptide |
| 06/19/2002 | EP1214943A1 T-cell therapeutics for transmissible spongiform encephalopathy and method for the manufacture of non-infective blood products and tissue derived products |
| 06/19/2002 | EP1214598A2 Screening for inhibitors of "paired helical filaments" |
| 06/19/2002 | EP1214453A1 Novel cell cycle checkpoint genes and proteins encoded thereby |
| 06/19/2002 | EP1214428A1 Method for producing active serine proteases and inactive variants |
| 06/19/2002 | EP1214425A1 Regulatory sequences and expression cassettes for yeasts |
| 06/19/2002 | EP1214422A1 Phosphatases which activate map kinase pathways |
| 06/19/2002 | EP1214417A2 Nucleic acids and proteins from group b streptococcus |
| 06/19/2002 | EP1214413A1 Human paralogue of a head trauma induced cytoplasmatic calcium binding protein |
| 06/19/2002 | EP1214409A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 06/19/2002 | EP1214401A2 Dna encoding the human serine protease c-e |
| 06/19/2002 | EP1214400A2 Zymogen activation system |
| 06/19/2002 | EP1214399A1 High level cytokine production with enhanced cell viability |
| 06/19/2002 | EP1214342A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 06/19/2002 | EP1214337A2 Proteins associated with cell differentiation |
| 06/19/2002 | EP1164838A4 Screening assay for antagonists of fgfr-mediated malignant cell transformation and tumor formation |
| 06/19/2002 | EP1015622A4 Practical in vitro sialylation of recombinant glycoproteins |
| 06/19/2002 | EP0900275B1 Methods and reagents for modulating apoptosis |
| 06/19/2002 | EP0859841B1 Protein/(poly)peptide libraries |
| 06/19/2002 | EP0714510B1 Natural killer cell-specific antigen and antibodies that identify the same |
| 06/19/2002 | EP0632817B1 Neurotrophic factors having altered receptor binding specificities |
| 06/19/2002 | EP0625204B1 Hepatitis therapeutics |
| 06/19/2002 | EP0462215B1 MOLECULAR CLONING OF GENOMIC AND cDNA SEQUENCES ENCODING CELLULAR RECEPTORS FOR POLIOVIRUS |
| 06/19/2002 | CN1354798A Process for preparation of pseudomonic acid A antibiotic by microbiological method |